TY - JOUR AU - Grande, E. AU - Díaz, Á AU - López, C. AU - Munarriz, J. AU - Reina, J. J. AU - Vera, R. AU - Bernárdez Ferrán, Beatriz AU - Aller, J. AU - Capdevila, J. AU - Garcia-Carbonero, R. AU - Jimenez Fonseca, P. AU - Trapero-Bertran, M. PY - 2019 SN - 2042-0188 UR - http://hdl.handle.net/20.500.11940/15472 AB - Background: Despite current interest, enthusiasm and progress in the development of therapies for gastroenteropancreatic (GEP) neuroendocrine tumors (NETs), there are substantial gaps in the published literature regarding cost-of-illness analyses,... LA - eng TI - Economics of gastroenteropancreatic neuroendocrine tumors: a systematic review DO - 10.1177/2042018819828217 T2 - THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM KW - CHUS VL - 10 ER -